Tailored cognitive-behavioral E-health care in patients with psoriasis.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON25268

Enrollment

130

Registered

2010-07-30

Start date

2010-06-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psoriasis

Interventions

The intervention of E-health tailored cognitive-behavioral therapy consists of tailored individual treatments with E-health treatment modules that target the most frequently experienced problems which

Eligibility

Inclusion criteria

Inclusion criteria: 1. Diagnosis of definite psoriasis; 2. Age above 18 years.

Exclusion criteria

Exclusion criteria: 1. Pregnancy; 2. Illiteracy; 3. Severe physical and/or psychiatric comorbidity that interfere with the study protocol; 4. Current psychological treatments.

Design outcomes

Primary

Measure	Time frame
The primary outcome is the impact of psoriasis on daily life, including its impact on physical and psychological functioning and daily activities at post-treatment and follow-up measurement at 12 months. The primary outcome measures are measured as follows: 1. Impact on daily life: Composite scores of: A. Itch (IHDL, Evers et al., 2007); B. Fatigue (CIS, Vercoulen et al., 1994). 2. Impact on psychological functioning: Composite scores of: A. Negative mood (IHDL, Evers et al., 2007); B. Anxiety (IHDL, Evers et al., 2007); C. Depression (BDI, Beck et al., 1988). 3. Impact on daily activities: A. Role limitations due to emotional and physical health problems (SF-36, Ware et al., 1993).	—

Measure

Time frame

The primary outcome is the impact of psoriasis on daily life, including its impact on physical and psychological functioning and daily activities at post-treatment and follow-up measurement at 12 months. The primary outcome measures are measured as follows: 1. Impact on daily life: Composite scores of: A. Itch (IHDL, Evers et al., 2007); B. Fatigue (CIS, Vercoulen et al., 1994). 2. Impact on psychological functioning: Composite scores of: A. Negative mood (IHDL, Evers et al., 2007); B. Anxiety (IHDL, Evers et al., 2007); C. Depression (BDI, Beck et al., 1988). 3. Impact on daily activities: A. Role limitations due to emotional and physical health problems (SF-36, Ware et al., 1993).

—

Secondary

Measure	Time frame
Secondary outcomes include effects on disease severity as well as compliance with regular care and health care use.	—

Contacts

Public ContactA.W.M. Evers

LUMC PO Box 9555

a.evers@fsw.leidenuniv.nl+31 (0)71 527 3627

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)